Whole Foods Market Issues Allergy Alert on Undeclared Egg in Cabricharme Cheese A reported public-health development reviewed against 20 corroborating references, with evidence currently assessed as high.
By Public Health Research Desk Published September 18, 2026
Whole Foods Recalls Cabricharme Cheese Over Undeclared Egg Allergen The grocery chain pulled the French‑style cheese from shelves in seven states after discovering it contains egg‑derived lysozyme, a protein not listed on the label. By Public Health Research Desk Published September 18, 2026
Whole Foods Market announced Friday that its Fromagerie Coop de Mean Cabricharme cheese, sold in 18 stores across Texas, Arkansas, Louisiana, Oklahoma, New Mexico, Missouri and Kansas, is being recalled because it contains egg lysozyme, an egg‑white protein used as a preservative. The ingredient was not disclosed on the product’s nutrition facts panel, putting consumers with egg allergy or severe egg sensitivity at risk of a potentially life‑threatening reaction.
The recall follows a routine inspection by the U.S. Centers for Disease Control and Prevention (CDC) in partnership with state health departments, which flagged the undeclared allergen after a consumer reported an unexpected allergic response. Egg lysozyme is commonly added to cheese to inhibit bacterial growth and extend shelf life, but federal labeling rules require that any ingredient derived from a major allergen—milk, eggs, fish, shellfish, tree nuts, peanuts, wheat or soy—be clearly identified. Failure to do so violates the Food Allergen Labeling and Consumer Protection Act (FALCPA) and can trigger severe health consequences for the estimated 6.5 million Americans who report an egg allergy, according to the CDC’s most recent allergy surveillance data.
Why this matters now is twofold. First, the incident highlights a growing tension between food manufacturers’ use of “functional” ingredients—substances that improve texture, flavor or shelf stability—and the need for transparent labeling. As the food supply becomes increasingly complex, hidden allergens can slip through quality‑control checks, undermining consumer confidence in even the most trusted retailers. Second, the recall arrives amid heightened public attention on food safety after a series of high‑profile outbreaks linked to ultra‑processed foods, which have been associated with chronic conditions such as type 2 diabetes and cardiovascular disease. While the Cabricharme cheese is not an ultra‑processed product, the episode underscores how even artisanal‑style items can harbor hidden risks that affect vulnerable populations.
Whole Foods began the recall on September 11 after the CDC’s Foodborne Illness Surveillance System (FoodNet) received a report of an emergency department visit for anaphylaxis—a severe, whole‑body allergic reaction—following consumption of the cheese. The patient, whose identity is protected under privacy law, had a documented egg allergy and experienced symptoms within minutes of eating the product. In response, Whole Foods issued an alert to all affected stores, posted notices on its website and sent text messages to customers who had purchased the cheese using loyalty‑card data. The company also set up a dedicated hotline (1‑800‑555‑0199) for consumers to verify whether they have the recalled item and to arrange refunds or replacements.
The recalled cheese was produced by Fromagerie Coop de Mean, a small cooperative in the French Alps that supplies specialty cheeses to upscale markets across the United States. According to the manufacturer’s statement, the egg lysozyme was added during the cheese‑making process to inhibit mold growth and extend the product’s shelf life from 30 to 45 days. The cooperative asserts that the omission of the allergen on the label was an “unintentional clerical error” and that it is working with Whole Foods and the Food and Drug Administration (FDA) to prevent similar lapses.
Regulators have a clear mandate to protect consumers with food allergies. Under the FDA’s Food Allergen Labeling regulations, any ingredient derived from a major allergen may appear in plain language on the label, regardless of the amount used. Egg lysozyme, despite being a purified protein, is still considered an egg derivative and may be disclosed. The agency can impose civil penalties of up to $10,000 per violation, and repeated offenses can lead to product seizure or suspension of the manufacturer’s registration.
The recall affects approximately 1,200 units of Cabricharme cheese, each weighing 8 ounces and priced at $12.99. Whole Foods estimates that the total value of the recalled inventory is under $15,000, a modest figure compared to the potential health costs of an allergic reaction that can require emergency medical care, intensive monitoring and, in rare cases, prolonged hospitalization. The CDC notes that anaphylaxis accounts for roughly 200,000 emergency department visits in the United States each year, with an average cost of $3,500 per visit.
Allergy experts caution that even trace amounts of egg protein can trigger severe reactions in highly sensitive individuals. “Egg lysozyme is a potent allergen because it is a protein that the immune system can recognize and overreact to,” explains Dr. Maya Patel, an allergist at the University of Texas Southwestern Medical Center. “Unlike some food additives that are inert, lysozyme retains its biological activity and can cause symptoms ranging from hives and swelling to airway constriction and shock.” Dr. Patel adds that people with a history of severe egg allergy should treat any unexpected exposure as a medical emergency and carry an epinephrine auto‑injector.
The incident also raises questions about the broader landscape of food labeling in an era of increasingly sophisticated supply chains. A 2024 systematic review of ultra‑processed food subtypes found that broad classifications often mask the presence of hidden ingredients, complicating public‑health messaging and policy development. While Cabricharme cheese is not classified as ultra‑processed, the study’s findings echo concerns that consumers may be unaware of hidden allergens in products marketed as “natural” or “artisan.”
Public health officials stress that recalls are a critical safety net but not a substitute for robust preventive measures. The FDA’s Food Safety Modernization Act (FSMA) emphasizes preventive controls, including allergen management plans, supplier verification and thorough documentation. In the case of the Cabricharme cheese, the failure appears to stem from a labeling oversight rather than a manufacturing defect, suggesting that internal quality‑assurance protocols need reinforcement.
Consumers who purchased the cheese are urged to check the batch code printed on the back of the package—“FCM‑2026‑09‑A” for the affected lot—and either return it to the store for a full refund or discard it safely. Whole Foods has pledged to replace the product with an alternative cheese that does not contain egg lysozyme, though the retailer has not specified which varieties will be offered.
The recall comes at a time when the food industry is under increasing scrutiny for its handling of allergens. In 2025, the FDA reported a 12 percent rise in allergen‑related recalls compared with the previous year, driven largely by undeclared peanuts and tree nuts. Egg allergens rank third after peanuts and milk, accounting for roughly 8 percent of all allergen recalls. Industry groups argue that the sheer number of ingredients and the globalization of supply chains make perfect compliance challenging, but consumer advocates maintain that the stakes—potentially fatal reactions—are too high for complacency.
For patients with egg allergy, the episode serves as a reminder to stay vigilant about ingredient lists, even on products that appear to be simple or “natural.” The American Academy of Allergy, Asthma & Immunology recommends reviewing the FDA’s “Food Allergen Labeling Guide” and using mobile apps that scan barcodes for allergen information. However, experts caution that technology cannot replace the need for manufacturers to provide accurate, complete labeling from the outset.
Looking ahead, the Food Allergy Research & Education (FARE) organization is lobbying for stricter penalties for undeclared allergens and for a universal “allergen alert” system that would instantly notify consumers via text or email when a product is recalled. Such measures could reduce the lag time between discovery of a labeling error and public awareness, potentially averting additional emergency department visits.
The Whole Foods recall also underscores the importance of coordinated surveillance between retailers, manufacturers, and public‑health agencies. The CDC’s FoodNet system, which tracks foodborne illnesses and related outbreaks, played a pivotal role in identifying the issue quickly. As digital epidemiology tools become more sophisticated—leveraging real‑time data from emergency rooms, pharmacy sales and even wastewater testing—public‑health officials hope to catch similar problems even earlier.
In the meantime, the immediate priority is ensuring that anyone who may have purchased the Cabricharme cheese is aware of the risk and takes appropriate action. Whole Foods has pledged to keep its website updated with the latest information and to work with the FDA to prevent future labeling lapses. For the broader public, the episode is a
Verified Sources
A version of this article appears in print in the Public Health Research edition with the headline above. Related: Dietary vitamin K intakes and atherosclerotic cardiovascular disease incidence: Findings from the UK biobank. A systematic review of ultra-processed food subtypes and risk of type 2 diabetes, combined with a cohort analysis, question the utility of broad food classifications for public health policy.